Cure8 research brief
Why This Matters
Older adults with mild-to-moderate UC may have different disease activity, treatment use, and priorities compared with younger patients. Understanding these differences can inform age-adapted outpatient management and support medication adherence.
Who Should Pay Attention
Older adult UC patients and caregivers; gastroenterologists and IBD clinicians; researchers interested in real-world IBD management and adherence.
Study Snapshot
What To Know
This study enrolled 429 outpatient UC patients across 47 IBD centers using a standardized questionnaire. The authors report 5-ASA (mesalamine) remained the first-line therapy in both age groups; corticosteroid use was lower in older adults. Older patients reported higher satisfaction with 5-ASA in several care domains.
Factors associated with better medication adherence included switching to biologics, having 3–4 physician visits during diagnosis, and greater perceived long-term efficacy. The article focuses on age-related differences in clinical phenotype, treatment patterns, and adherence rather than testing a new drug or intervention.
The data are cross-sectional and observational, so associations do not prove causation.
Keep In Mind
Results come from a multicenter cross-sectional survey of outpatients; observational design limits causal inference. The study emphasizes real-world patterns (medication use, satisfaction, and adherence) rather than testing new therapies.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.